• AXIS Clinicals successfully completes 14th US FDA audit (June 2016)
  • AXIS Clinicals successfully completes US FDA audit for ICP-OES services (March 2016)
  • AXIS Clinicals successfully completes 7th ANVISA – Brazil audit (March 2015)
  • AXIS Clinicals successfully completes WHO audit (March 2015)
  • AXIS Clinicals successfully completes 3rd MHRA audit (Sep 2014)
  • BA-BE studies conducted at AXIS Clinicals are accepted by Chile – ISP

Our Core Values

Our values define who we are and the kind of company we aim to be, Click here for poster

  • Value Based Leadership: Our mission outlines the value that provides the foundation to perform as a Global service provider and as individual employees who continue to put the needs of the Customers we serve first.
  • Integrity: We do what is right:
    • Committed to conduct our business with individual and organizational Integrity
    • Compliance with Local and International laws
    • Reliable, honest and trustworthy in our dealings
  • Responsibility: We hold ourselves accountable for our actions:
    • Take personal responsibility in everything that we do and we lead by example
    • Treat our Organization's reputation as our own
    • Committed to a culture of shared responsibility that promotes high performance

 

 

Fact sheet

  • Over 1,600 clinical studies completed since inception
  • Over 290 bioanalytical methods developed
  • Over 38 successful Regulatory audits
  • Global footprint of operations with sites in India, U.S, Mexico & Thailand.
  • Two clinical facilities in India
  • 60+ National and International Pharma/Biotech Sponsor companies working with AXIS
  • US FDA : 200+ approvals, EMEA : 70+ approvals, Canada : 20+ approvals, Australia : 30+ approvals
  • 350+ staff working globally
  • Huge database of patient population in various therapeutic areas viz. Cardiology, Opthalmology, Schizophrenia, Diabetology, Oncology. Orthopedics etc..

Copyright Axis Clinicals - All Rights Reserved

Design By Graypixel